Management of women who test positive for high-risk types of human papillomavirus: the HART study.

By Jack Cuzick, A. Szarewski, H. Cubie, G. Hulman, H. Kitchener, D. Luesley, E. Mcgoogan, U. Menon, G. Terry, R. Edwards and 7 more. The Lancet, 2003

604 citations recorded by the source corpus.

Subfields: Epidemiology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/047758d2ba684ade04596d181682b3315db6bdd2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Clavel
2. K. Petry
3. P. Birembaut
4. H. Hoyer
5. S. Ratnam
6. S. Kulasingam
7. A. Szarewski
8. P. Sasieni

Citations in the corpus

• Overview of the European and North American studies on HPV testing in primary cervical cancer screening (2006, methodology): “It is generally believed that only persistent HPV infections are associated with pre-cancerous lesions.[ 11 ][16][17][18] Currently, persistence of HPV can be determined only by repeated tests 6-12 months apart.”